EC Draft Regulation for Electronic IFU

The European Commission (EC) has released a draft regulation that expands the device categories authorized to provide instructions for use in electronic form instead of paper instructions to include certain medical devices including SaMD.  Articles 3 and 5 describe the eligible devices and conditions where this is the case, while Articles 6 and 7 detail other labeling and electronic IFU requirements.  The regulation is in the feedback phase and Commission adoption is planned for the second quarter of 2021.

The draft basically lays out the process manufacturers must follow in order to maintain compliance during the transition. The decision to switch must include the use of a risk assessment, found in Article 4, to address any issues instructions for use in electronic form may bring as they relate to a specific product. The regulation points out that users must be able to obtain a paper copy upon request, as well as have access to the electronic IFU on the manufacturers website in the official language where the device is offered.  As would be expected, any content on the website and electronic IFU is still subject to the same requirements that exist for paper IFUs, to include Regulation (EU) 2017/745 and Regulation (EU) 2016/679.

Manufacturers may provide instructions for use in electronic form instead of in paper form where those instructions relate to any of the following devices:

  • implantable and active implantable medical devices and their accessories covered by Regulation (EU) 2017/745
  • fixed installed medical devices covered by Regulation 2017/745
  • medical devices and their accessories covered by Regulation (EU) 2017/745 and fitted with a built-in system visually displaying the instructions for use

Keep in mind that the draft regulation appears to be limiting this provision of electronic IFU to professional users only.  Specifically the draft specifies the following conditions:

  • the devices and accessories are intended for exclusive use by professional users, and
  • the use by other persons is not reasonably foreseeable

For software covered by Regulation (EU) 2017/745, manufacturers may provide instructions for use in electronic form by means of the software itself instead of in paper form.

Devices not covered can be found in Annex XVI of Regulation (EU) 2017/745.

The draft can be found at https://ec.europa.eu/info/law/better-regulation/have-your-say/initiatives/12954-Medical-devices-online-manuals-replacing-paper-instructions_en

SoftwareCPR Training Courses:

IEC 62304 and other emerging standards for Medical Device and HealthIT Software

Our flagship course for preparing regulatory, quality, engineering, operations, and others for the activities and documentation expected for IEC 62304 conformance and for FDA expectations. The goal is to educate on the intent and purpose so that the participants are able to make informed decisions in the future.  Focus is not simply what the standard says, but what is meant and discuss examples and approaches one might implement to comply.  Special deep discount pricing available to FDA attendees and other regulators.

3-days onsite with group exercises, quizzes, examples, Q&A.

Instructor: Brian Pate

Next public offering:  TBD

Email training@softwarecpr.com to request a special pre-registration discount.  Limited number of pre-registration coupons.

Registration Link:

TBD

 


 

Being Agile & Yet Compliant (Public or Private)

Our SoftwareCPR unique approach to incorporating agile and lean engineering to your medical device software process training course is now open for scheduling!

  • Agile principles that align well with medical
  • Backlog management
  • Agile risk management
  • Incremental and iterative software development lifecycle management
  •  Frequent release management
  • And more!

2-days onsite (4 days virtual) with group exercises, quizzes, examples, Q&A.

Instructors: Mike Russell, Ron Baerg

Next public offering: March 7 & 28, 2024

Virtual via Zoom

Registration Link:

Register Now

 


 

Medical Device Cybersecurity (Public or Private)

This course takes a deep dive into the US FDA expectations for cybersecurity activities in the product development process with central focus on the cybersecurity risk analysis process. Overall approach will be tied to relevant standards and FDA guidance documentation. The course will follow the ISO 14971:2019 framework for overall structure but utilize IEC 62304, IEC 81001-5-1, and AAMI TIR57 for specific details regarding cybersecurity planning, risk characterization, threat modeling, and control strategies.

2-days onsite with group exercises, quizzes, examples, Q&A.

Instructor: Dr Peter Rech, 2nd instructor (optional)

Next public offering:  TBD

Corporate Office

15148 Springview St.
Tampa, FL 33624
USA
+1-781-721-2921
Partners located in the US (CA, FL, MA, MN, TX) and Canada.